However, the value of tumoral c-Met expression as an independent prognostic indicator in HNSCC remains controversial due to inconsistent reports regarding which clinical parameters significantly correlate with c-Met expression (Table 1). The gene discussed is MET; the disease is head and neck squamous cell carcinoma.